SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-027996
Filing Date
2019-08-01
Accepted
2019-08-01 16:36:45
Documents
74
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eidx-10q_20190630.htm 10-Q 2341752
2 EX-10.1 eidx-ex101_475.htm EX-10.1 391812
3 EX-31.1 eidx-ex311_6.htm EX-31.1 17875
4 EX-31.2 eidx-ex312_8.htm EX-31.2 17952
5 EX-32.1 eidx-ex321_7.htm EX-32.1 9942
6 EX-32.2 eidx-ex322_9.htm EX-32.2 9924
  Complete submission text file 0001564590-19-027996.txt   8353388

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT eidx-20190630.xml EX-101.INS 1673512
8 XBRL TAXONOMY EXTENSION SCHEMA eidx-20190630.xsd EX-101.SCH 67891
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eidx-20190630_cal.xml EX-101.CAL 39624
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eidx-20190630_def.xml EX-101.DEF 211351
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE eidx-20190630_lab.xml EX-101.LAB 478618
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eidx-20190630_pre.xml EX-101.PRE 370343
Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Filer) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38533 | Film No.: 19993194
SIC: 2834 Pharmaceutical Preparations